Under detection of interstitial lung disease in Juvenile Systemic Sclerosis (JSSC) utilizing pulmonary function tests. Results from the juvenile scleroderma inception cohort

Ivan Foeldvari, Bernd Hinrichs, jSSc Collaborative Group, Kathryn S. Torok, Maria Jose Santos, Ozgur Kasapcopur, Amra Adrovic, Valda Stanevicha, Flavio Sztajnbok, Maria Teresa Terreri, A. P. Sakamoto, Ekaterina Alexeeva, M. Katsikas, Jordi Anton, Vanessa Smith, Tadej Avcin, Rolando Cimaz, Mikhail Kostik, Thomas Lehman, Walter‐Alberto Sifuentes‐GiraldoSimone Appenzeller, Mahesh Janarthanan, M. Moll, D. Nemcova, Dieneke Schonenberg‐Meinema, Cristina Battagliotti, Lillemor Berntson, Blanca E.R.G. Bica, Jurgen Brunner, P. Costa Reis, Despina Eleftheriou, L. Harel, Gerd Horneff, Tilmann Kallinich, D. Lazarevic, Kirsten Minden, Susan Nielsen, Farzana Nuruzzaman, Anjali Patwardhan, Yosef Uziel, Nicola Helmus

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

Introduction: Juvenile systemic sclerosis (jSSc) has a prevalence in around 3 in a million children. Pulmonary involvement occurs in approximately 40 % in the international juvenile systemic scleroderma cohort (JSScC). Traditionally in jSSc, pulmonary function testing (PFT) with FVC and DLCO are used for screening and computed tomography (HRCT) was more reserved for those with abnormal PFTs. More recently, it has become apparent that PFTs might not be sensitive enough for detecting interstitial lung disease (ILD) in children. Objectives: To assess the sensitivity and specificity of FVC and DLCO assessment to detect ILD Methods: The international juvenile systemic scleroderma cohort (JSScC) database was queried for available patients with recorded PFT parameters and HRCT performed to determine sensitivity of PFTs detecting disease process. Results: Of 129 patients in the jSScC, 67 patients had both CT imaging and an FVC reading from PFTs for direct comparison. DLCO readings were also captured but not in as many patients with tandem HRCT (n =55 DCLO and HRCT scan). Therefore, initial analyses focused on the sensitivity, specificity and accuracy of the FVC value from the PFTs to capture the diagnosis of interstitial lung disease as determined by HRCT. Overall, 49% of the patients had ILD determined by HRCT, with 60% of patients having normal FVC (>80%) with positive HRCT findings, and 24% of patients having normal DLCO (> 80%) with positive HRCT findings. Fourteen percent (n = 3/21) of patients with both FVC and DLCO values within the normal range had a positive HRCT finding. Conclusion: The sensitivity of the FVC in the JSScC cohort in detecting ILD was only 39%. Relying on PFTs alone for screening for ILD in juvenile systemic sclerosis would have missed the detection of ILD in almost 2/3 of the sample cohort, supporting the use of HRCT for detection of ILD in children with SSc. In addition, the cut off utilized, of less than 80% of predicted FVC or DLCO could be too low for pediatric patients to exclude beginning ILD. This pilot data needs confirmation in a larger patient population. Supported by the "Joachim Herz Stiftung
Original languageEnglish
Pages (from-to)40-41
JournalPediatric Rheumatology
Volume18
Issue numberSuppl.2
Publication statusPublished - 2020
Event26th European
Paediatric Rheumatology Congress
-
Duration: 23 Oct 202026 Oct 2020
Conference number: 26

Field of Science

  • 3.2 Clinical medicine

Publication Type

  • 3.4. Other publications in conference proceedings (including local)

Fingerprint

Dive into the research topics of 'Under detection of interstitial lung disease in Juvenile Systemic Sclerosis (JSSC) utilizing pulmonary function tests. Results from the juvenile scleroderma inception cohort'. Together they form a unique fingerprint.

Cite this